Insiders · SLS

SLS insider transactions

SELLAS Life Sciences Group Inc. (SLS) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for SLS

• 149d
  Director Varian John was granted 50,000 shares, increasing direct ownership by 218% to 72,900 units (SEC Form 4)

  4 - SELLAS Life Sciences Group, Inc. (0001390478) (Issuer)
• 149d
  Director Van Nostrand Robert L was granted 50,000 shares, increasing direct ownership by 152% to 82,900 units (SEC Form 4)

  4 - SELLAS Life Sciences Group, Inc. (0001390478) (Issuer)
• 149d
  Director Scheinberg David A was granted 50,000 shares, increasing direct ownership by 217% to 73,082 units (SEC Form 4)

  4 - SELLAS Life Sciences Group, Inc. (0001390478) (Issuer)
• 149d
  SVP, Chief Development Officer Cicic Dragan was granted 300,000 shares, increasing direct ownership by 116% to 557,805 units (SEC Form 4)

  4 - SELLAS Life Sciences Group, Inc. (0001390478) (Issuer)
• 149d
  CFO Burns John Thomas was granted 300,000 shares, increasing direct ownership by 118% to 554,327 units (SEC Form 4)

  4 - SELLAS Life Sciences Group, Inc. (0001390478) (Issuer)
• 149d
  Director Kalin Katherine Bach was granted 50,000 shares, increasing direct ownership by 48% to 154,400 units (SEC Form 4)

  4 - SELLAS Life Sciences Group, Inc. (0001390478) (Issuer)
• 149d
  Director Wasman Jane was granted 50,000 shares, increasing direct ownership by 117% to 92,900 units (SEC Form 4)

  4 - SELLAS Life Sciences Group, Inc. (0001390478) (Issuer)
• 184d
  SVP, Chief Development Officer Cicic Dragan disposed of $95,700 worth of shares (63,800 units at $1.50), decreasing direct ownership by 20% to 257,805 units (SEC Form 4)

  4 - SELLAS Life Sciences Group, Inc. (0001390478) (Issuer)
• 184d
  CFO Burns John Thomas disposed of $87,888 worth of shares (58,592 units at $1.50), decreasing direct ownership by 19% to 254,327 units (SEC Form 4)

  4 - SELLAS Life Sciences Group, Inc. (0001390478) (Issuer)
• 184d
  President and CEO Stergiou Angelos M. disposed of $280,599 worth of shares (187,066 units at $1.50), decreasing direct ownership by 21% to 686,966 units (SEC Form 4)

  4 - SELLAS Life Sciences Group, Inc. (0001390478) (Issuer)
• 199d
  Director Kalin Katherine Bach bought $100,806 worth of shares (63,400 units at $1.59), increasing direct ownership by 155% to 104,400 units (SEC Form 4)

  4 - SELLAS Life Sciences Group, Inc. (0001390478) (Issuer)
• 360d
  Director Van Nostrand Robert L bought $14,800 worth of shares (10,000 units at $1.48), increasing direct ownership by 96% to 20,400 units (SEC Form 4)

  4 - SELLAS Life Sciences Group, Inc. (0001390478) (Issuer)
• 370d
  Director Wasman Jane bought $33,800 worth of shares (20,000 units at $1.69), increasing direct ownership by 192% to 30,400 units (SEC Form 4)

  4 - SELLAS Life Sciences Group, Inc. (0001390478) (Issuer)
• 381d
  Director Kalin Katherine Bach bought $36,000 worth of shares (20,000 units at $1.80), increasing direct ownership by 95% to 41,000 units (SEC Form 4)

  4 - SELLAS Life Sciences Group, Inc. (0001390478) (Issuer)
• 509d
  CFO Burns John Thomas was granted 194,300 shares, increasing direct ownership by 185% to 299,062 units (SEC Form 4)

  4 - SELLAS Life Sciences Group, Inc. (0001390478) (Issuer)
• 509d
  President and CEO Stergiou Angelos M. was granted 500,900 shares, increasing direct ownership by 140% to 859,032 units (SEC Form 4)

  4 - SELLAS Life Sciences Group, Inc. (0001390478) (Issuer)
• 509d
  Director Scheinberg David A was granted 12,500 shares, increasing direct ownership by 118% to 23,082 units (SEC Form 4)

  4 - SELLAS Life Sciences Group, Inc. (0001390478) (Issuer)
• 509d
  Director Wasman Jane was granted 12,500 shares, increasing direct ownership by 120% to 22,900 units (SEC Form 4)

  4 - SELLAS Life Sciences Group, Inc. (0001390478) (Issuer)
• 509d
  Director Van Nostrand Robert L was granted 12,500 shares, increasing direct ownership by 120% to 22,900 units (SEC Form 4)

  4 - SELLAS Life Sciences Group, Inc. (0001390478) (Issuer)
• 509d
  Director Kalin Katherine Bach was granted 12,500 shares, increasing direct ownership by 147% to 21,000 units (SEC Form 4)

  4 - SELLAS Life Sciences Group, Inc. (0001390478) (Issuer)
• 509d
  Director Varian John was granted 12,500 shares, increasing direct ownership by 120% to 22,900 units (SEC Form 4)

  4 - SELLAS Life Sciences Group, Inc. (0001390478) (Issuer)
• 509d
  SVP, Chief Development Officer Cicic Dragan was granted 194,300 shares, increasing direct ownership by 168% to 309,628 units (SEC Form 4)

  4 - SELLAS Life Sciences Group, Inc. (0001390478) (Issuer)
• 549d
  SVP, Chief Development Officer Cicic Dragan disposed of $9,329 worth of shares (8,256 units at $1.13), decreasing direct ownership by 7% to 115,328 units (SEC Form 4)

  4 - SELLAS Life Sciences Group, Inc. (0001390478) (Issuer)
• 549d
  President and CEO Stergiou Angelos M. disposed of $31,967 worth of shares (28,289 units at $1.13), decreasing direct ownership by 7% to 358,132 units (SEC Form 4)

  4 - SELLAS Life Sciences Group, Inc. (0001390478) (Issuer)
• 549d
  CFO Burns John Thomas disposed of $8,096 worth of shares (7,165 units at $1.13), decreasing direct ownership by 6% to 104,762 units (SEC Form 4)

  4 - SELLAS Life Sciences Group, Inc. (0001390478) (Issuer)
• 710d
  New insider Cicic Dragan claimed ownership of 118,584 shares (SEC Form 3)

  3 - SELLAS Life Sciences Group, Inc. (0001390478) (Issuer)
• 865d
  Stergiou Angelos M. was granted 159,000 shares, increasing direct ownership by 73% to 376,421 units (SEC Form 4)

  4 - SELLAS Life Sciences Group, Inc. (0001390478) (Issuer)
• 865d
  Wood Barbara A was granted 35,000 shares, increasing direct ownership by 43% to 117,225 units (SEC Form 4)

  4 - SELLAS Life Sciences Group, Inc. (0001390478) (Issuer)
• 865d
  Scheinberg David A was granted 6,000 shares, increasing direct ownership by 131% to 10,582 units (SEC Form 4)

  4 - SELLAS Life Sciences Group, Inc. (0001390478) (Issuer)
• 865d
  Kalin Katherine Bach was granted 6,000 shares, increasing direct ownership by 240% to 8,500 units (SEC Form 4)

  4 - SELLAS Life Sciences Group, Inc. (0001390478) (Issuer)
• 865d
  Wasman Jane was granted 6,000 shares, increasing direct ownership by 136% to 10,400 units (SEC Form 4)

  4 - SELLAS Life Sciences Group, Inc. (0001390478) (Issuer)
• 865d
  Varian John was granted 6,000 shares, increasing direct ownership by 136% to 10,400 units (SEC Form 4)

  4 - SELLAS Life Sciences Group, Inc. (0001390478) (Issuer)
• 865d
  Burns John Thomas was granted 47,000 shares, increasing direct ownership by 86% to 101,927 units (SEC Form 4)

  4 - SELLAS Life Sciences Group, Inc. (0001390478) (Issuer)
• 865d
  Francomano Robert was granted 20,000 shares, increasing direct ownership by 96% to 40,918 units (SEC Form 4)

  4 - SELLAS Life Sciences Group, Inc. (0001390478) (Issuer)
• 865d
  Van Nostrand Robert L was granted 6,000 shares, increasing direct ownership by 136% to 10,400 units (SEC Form 4)

  4 - SELLAS Life Sciences Group, Inc. (0001390478) (Issuer)
• 912d
  Wood Barbara A disposed of $4,449 worth of shares (4,119 units at $1.08), decreasing direct ownership by 5% to 82,225 units (SEC Form 4)

  4 - SELLAS Life Sciences Group, Inc. (0001390478) (Issuer)
• 912d
  Stergiou Angelos M. disposed of $13,249 worth of shares (12,268 units at $1.08), decreasing direct ownership by 5% to 217,421 units (SEC Form 4)

  4 - SELLAS Life Sciences Group, Inc. (0001390478) (Issuer)
• 912d
  Francomano Robert disposed of $1,169 worth of shares (1,082 units at $1.08), decreasing direct ownership by 5% to 20,918 units (SEC Form 4)

  4 - SELLAS Life Sciences Group, Inc. (0001390478) (Issuer)
• 912d
  Burns John Thomas disposed of $3,163 worth of shares (2,929 units at $1.08), decreasing direct ownership by 5% to 54,927 units (SEC Form 4)

  4 - SELLAS Life Sciences Group, Inc. (0001390478) (Issuer)
• 1220d
  SEC Form 4: Wood Barbara A was granted 20,000 shares, increasing direct ownership by 35% to 76,344 units

  4 - SELLAS Life Sciences Group, Inc. (0001390478) (Issuer)
• 1220d
  SEC Form 4: Burns John Thomas was granted 20,000 shares, increasing direct ownership by 68% to 49,347 units

  4 - SELLAS Life Sciences Group, Inc. (0001390478) (Issuer)
• 1220d
  SEC Form 4: Stergiou Angelos M. was granted 58,000 shares, increasing direct ownership by 36% to 219,689 units

  4 - SELLAS Life Sciences Group, Inc. (0001390478) (Issuer)
• 1220d
  SEC Form 4: Francomano Robert was granted 12,000 shares

  4 - SELLAS Life Sciences Group, Inc. (0001390478) (Issuer)
• 1220d
  SEC Form 4: Varian John was granted 2,500 shares, increasing direct ownership by 132% to 4,400 units

  4 - SELLAS Life Sciences Group, Inc. (0001390478) (Issuer)
• 1220d
  SEC Form 4: Wasman Jane was granted 2,500 shares, increasing direct ownership by 132% to 4,400 units

  4 - SELLAS Life Sciences Group, Inc. (0001390478) (Issuer)
• 1220d
  SEC Form 4: Van Nostrand Robert L was granted 2,500 shares, increasing direct ownership by 132% to 4,400 units

  4 - SELLAS Life Sciences Group, Inc. (0001390478) (Issuer)
• 1220d
  SEC Form 4: Scheinberg David A was granted 2,500 shares, increasing direct ownership by 120% to 4,582 units

  4 - SELLAS Life Sciences Group, Inc. (0001390478) (Issuer)
• 1220d
  SEC Form 4: Kalin Katherine Bach was granted 2,500 shares

  4 - SELLAS Life Sciences Group, Inc. (0001390478) (Issuer)
• 1280d
  SEC Form 4: Stergiou Angelos M. sold $16,938 worth of shares (6,494 units at $2.61), decreasing direct ownership by 4% to 161,689 units (for withholding tax)

  4 - SELLAS Life Sciences Group, Inc. (0001390478) (Issuer)
• 1280d
  SEC Form 4: Burns John Thomas sold $3,002 worth of shares (1,159 units at $2.59), decreasing direct ownership by 4% to 29,347 units (tax withholding)

  4 - SELLAS Life Sciences Group, Inc. (0001390478) (Issuer)
• 1280d
  SEC Form 4: Wood Barbara A sold $5,576 worth of shares (2,153 units at $2.59), decreasing direct ownership by 4% to 56,344 units (for withholding tax)

  4 - SELLAS Life Sciences Group, Inc. (0001390478) (Issuer)
• 1391d
  SEC Form 4 filed by Kalin Katherine Bach

  4 - SELLAS Life Sciences Group, Inc. (0001390478) (Issuer)
• 1391d
  SEC Form 3: New insider Kalin Katherine Bach claimed no ownership of stock in the company

  3 - SELLAS Life Sciences Group, Inc. (0001390478) (Issuer)
• 1545d
  SEC Form 4 filed by Francomano Robert

  4 - SELLAS Life Sciences Group, Inc. (0001390478) (Issuer)
• 1546d
  SEC Form 3: New insider Francomano Robert claimed no ownership of stock in the company

  3 - SELLAS Life Sciences Group, Inc. (0001390478) (Issuer)
• 1587d
  SEC Form 4: Wood Barbara A was granted 13,000 shares, increasing direct ownership by 31% to 55,028 units

  4 - SELLAS Life Sciences Group, Inc. (0001390478) (Issuer)
• 1587d
  SEC Form 4: Wasman Jane was granted 1,900 shares

  4 - SELLAS Life Sciences Group, Inc. (0001390478) (Issuer)
• 1587d
  SEC Form 4: Varian John was granted 1,900 shares

  4 - SELLAS Life Sciences Group, Inc. (0001390478) (Issuer)
• 1587d
  SEC Form 4: Van Nostrand Robert L was granted 1,900 shares

  4 - SELLAS Life Sciences Group, Inc. (0001390478) (Issuer)
• 1587d
  SEC Form 4: Stergiou Angelos M. was granted 44,000 shares, increasing direct ownership by 36% to 165,167 units

  4 - SELLAS Life Sciences Group, Inc. (0001390478) (Issuer)